- Home
- HUMA vs OSUR Comparison
HUMA vs OSUR Comparison
Compare HUMA & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- OSUR
- Stock Information
- Founded
- HUMA 2004
- OSUR 2000
- Country
- HUMA United States
- OSUR United States
- Employees
- HUMA 220
- OSUR N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- HUMA Health Care
- OSUR Health Care
- Exchange
- HUMA Nasdaq
- OSUR Nasdaq
- Market Cap
- HUMA 367.6M
- OSUR 223.0M
- IPO Year
- HUMA N/A
- OSUR 1986
- Fundamental
- Price
- HUMA $2.31
- OSUR $3.00
- Analyst Decision
- HUMA Strong Buy
- OSUR Hold
- Analyst Count
- HUMA 7
- OSUR 1
- Target Price
- HUMA $13.00
- OSUR $3.00
- AVG Volume (30 Days)
- HUMA 4.1M
- OSUR 823.3K
- Earning Date
- HUMA 08-12-2025
- OSUR 08-05-2025
- Dividend Yield
- HUMA N/A
- OSUR N/A
- EPS Growth
- HUMA N/A
- OSUR N/A
- EPS
- HUMA N/A
- OSUR N/A
- Revenue
- HUMA $517,000.00
- OSUR $161,626,000.00
- Revenue This Year
- HUMA N/A
- OSUR N/A
- Revenue Next Year
- HUMA $896.45
- OSUR $6.20
- P/E Ratio
- HUMA N/A
- OSUR N/A
- Revenue Growth
- HUMA N/A
- OSUR N/A
- 52 Week Low
- HUMA $1.15
- OSUR $2.36
- 52 Week High
- HUMA $9.79
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- HUMA 48.99
- OSUR 54.60
- Support Level
- HUMA $2.26
- OSUR $2.78
- Resistance Level
- HUMA $2.79
- OSUR $3.03
- Average True Range (ATR)
- HUMA 0.19
- OSUR 0.13
- MACD
- HUMA -0.06
- OSUR 0.01
- Stochastic Oscillator
- HUMA 7.46
- OSUR 58.93
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.